Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FRC
First Republic Bank
FRC
|
+$734M |
| 2 |
Boeing
BA
|
+$493M |
| 3 |
Pfizer
PFE
|
+$478M |
| 4 |
UnitedHealth
UNH
|
+$440M |
| 5 |
Honeywell
HON
|
+$364M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.05B |
| 2 |
Advanced Micro Devices
AMD
|
+$447M |
| 3 |
TSMC
TSM
|
+$441M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$372M |
| 5 |
ExxonMobil
XOM
|
+$321M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.34% |
| 2 | Technology | 16.84% |
| 3 | Consumer Discretionary | 12.66% |
| 4 | Industrials | 10.11% |
| 5 | Consumer Staples | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AINC
2651
DELISTED
Ashford Inc.
AINC
| $757K | ﹤0.01% |
59,653
-1,000
| -2% | -$13.3K |
|
|
AAIC
2652
DELISTED
Arlington Asset Investment Corp.
AAIC
| $756K | ﹤0.01% |
264,488
+41,639
| +19% | +$123K |
|
2653
Pennant Group
PNTG
$1.4B
| $755K | ﹤0.01% |
+52,900
| New | +$663K |
|
2654
Tenaya Therapeutics
TNYA
$158M
| $755K | ﹤0.01% |
264,900
+55,821
| +27% | +$157K |
|
2655
Zymeworks
ZYME
$1.6B
| $754K | ﹤0.01% |
83,400
-36,600
| -31% | -$319K |
|
2656
CorMedix
CRMD
$592M
| $752K | ﹤0.01% |
181,724
+108,124
| +147% | +$442K |
|
|
BBBY
2657
DELISTED
Bed Bath & Beyond Inc
BBBY
| $749K | ﹤0.01% |
+1,752,660
| New | +$3.61M |
|
2658
BioLife Solutions
BLFS
$1.57B
| $746K | ﹤0.01% |
+34,300
| New | +$771K |
|
2659
Rimini Street
RMNI
$447M
| $744K | ﹤0.01% |
180,630
-49,100
| -21% | -$221K |
|
|
ENFN
2660
DELISTED
Enfusion, Inc.
ENFN
| $743K | ﹤0.01% |
+70,800
| New | +$780K |
|
2661
Oportun Financial
OPRT
$267M
| $742K | ﹤0.01% |
192,309
-191
| -0.1% | -$1.07K |
|
2662
TELA Bio
TELA
$33.1M
| $742K | ﹤0.01% |
69,700
+968
| +1% | +$10.7K |
|
|
MITT
2663
TPG Mortgage Investment Trust
MITT
$227M
| $741K | ﹤0.01% |
128,900
+20,600
| +19% | +$125K |
|
2664
NI Holdings
NODK
$318M
| $740K | ﹤0.01% |
56,891
+400
| +0.7% | +$5.36K |
|
2665
Riskified
RSKD
$698M
| $740K | ﹤0.01% |
131,277
-133,423
| -50% | -$741K |
|
2666
ThredUp
TDUP
$801M
| $739K | ﹤0.01% |
292,200
+41,988
| +17% | +$78.3K |
|
2667
Educational Development Corp
EDUC
$11.8M
| $737K | ﹤0.01% |
250,745
-3,800
| -1% | -$13K |
|
2668
TPG
TPG
$7.43B
| $736K | ﹤0.01% |
25,100
-199,900
| -89% | -$6.28M |
|
2669
Affinity Bancshares
AFBI
$140M
| $733K | ﹤0.01% |
51,204
-8,000
| -14% | -$120K |
|
|
TMHC
2670
DELISTED
Taylor Morrison
TMHC
| $733K | ﹤0.01% |
+19,153
| New | +$673K |
|
2671
Shattuck Labs
STTK
$696M
| $730K | ﹤0.01% |
248,167
-8,133
| -3% | -$28.8K |
|
2672
Luxfer Holdings
LXFR
$459M
| $727K | ﹤0.01% |
43,000
+9,400
| +28% | +$151K |
|
|
SPPI
2673
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $726K | ﹤0.01% |
967,400
-99,000
| -9% | -$72.2K |
|
|
EFXT
2674
Enerflex
EFXT
$2.66B
| $724K | ﹤0.01% |
+121,700
| New | +$797K |
|
2675
Tonix Pharmaceuticals
TNXP
$170M
| $723K | ﹤0.01% |
61
+1
| +2% | +$17.2K |
|
Similar funds
Renaissance Technologies's Q1 2023 Portfolio in Review
As of Q1 2023, Renaissance Technologies held 4,600 positions worth $75.4B, up 3.1% from $73.1B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies's Q1 2023 filing shows 524 new, 1,665 increased, 1,689 reduced and 668 closed positions. Its largest new stake was Honeywell: 1,937,917 shares worth $349M. The largest sale was Apple, an estimated $1.05B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Technology and Consumer Discretionary.
- Renaissance Technologies's largest Q1 2023 buy was Honeywell: 1,937,917 shares worth $349M.
- Renaissance Technologies added most to First Republic Bank in Q1 2023, an estimated $734M increase.
- Renaissance Technologies's biggest Q1 2023 reduction was Apple, cutting an estimated $1.05B.
- Renaissance Technologies fully exited Advanced Micro Devices in Q1 2023, selling an estimated $447M.
- Renaissance Technologies's ten largest holdings make up 11% of its $75.4B portfolio in Q1 2023.
- Renaissance Technologies opened 524 new positions and closed 668 in Q1 2023.
- Renaissance Technologies's portfolio value rose 3.1% quarter-over-quarter to $75.4B.
Based on Renaissance Technologies's 13F filing for Q1 2023, filed 12 May 2023.